108 related articles for article (PubMed ID: 33966314)
1. SARS-CoV-2 vaccine-related neurological complications need large collaborative studies, not single case reports or small descriptive series.
Leys D; Edwards M; Vonck K; Taba P; Moro E; Chan A; Sommer C
Eur J Neurol; 2021 Oct; 28(10):3223. PubMed ID: 33966314
[No Abstract] [Full Text] [Related]
2. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.
García-Grimshaw M; Ceballos-Liceaga SE; Hernández-Vanegas LE; Núñez I; Hernández-Valdivia N; Carrillo-García DA; Michel-Chávez A; Galnares-Olalde JA; Carbajal-Sandoval G; Del Mar Saniger-Alba M; Carrillo-Mezo RA; Fragoso-Saavedra S; Espino-Ojeda A; Blaisdell-Vidal C; Mosqueda-Gómez JL; Sierra-Madero J; Pérez-Padilla R; Alomía-Zegarra JL; López-Gatell H; Díaz-Ortega JL; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
Clin Immunol; 2021 Aug; 229():108786. PubMed ID: 34147649
[TBL] [Abstract][Full Text] [Related]
3. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
Front Immunol; 2021; 12():653786. PubMed ID: 33981305
[TBL] [Abstract][Full Text] [Related]
4. Functional neurological disorder after COVID-19 vaccination.
Ercoli T; Lutzoni L; Orofino G; Muroni A; Defazio G
Neurol Sci; 2021 Oct; 42(10):3989-3990. PubMed ID: 34324120
[No Abstract] [Full Text] [Related]
5. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
6. [The neurology of COVID-19].
Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
8. The potential neurological effect of the COVID-19 vaccines: A review.
Lu L; Xiong W; Mu J; Zhang Q; Zhang H; Zou L; Li W; He L; Sander JW; Zhou D
Acta Neurol Scand; 2021 Jul; 144(1):3-12. PubMed ID: 33779985
[TBL] [Abstract][Full Text] [Related]
9. Functional Neurological Disorders and COVID-19 Vaccination.
Ng JH; Chaudhuri KR; Tan EK
Ann Neurol; 2021 Aug; 90(2):328. PubMed ID: 34231246
[No Abstract] [Full Text] [Related]
10. Neurological Complications of COVID-19 in Children.
Ahmad S
Pediatr Ann; 2021 Jun; 50(6):e259-e263. PubMed ID: 34115563
[TBL] [Abstract][Full Text] [Related]
11. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.
Baig AM; Sanders EC
ACS Chem Neurosci; 2020 Jun; 11(12):1701-1703. PubMed ID: 32469504
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS
Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940
[TBL] [Abstract][Full Text] [Related]
13. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.
Iroegbu JD; Ifenatuoha CW; Ijomone OM
Neurol Sci; 2020 Jun; 41(6):1329-1337. PubMed ID: 32424503
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19.
Tandon M; Kataria S; Patel J; Mehta TR; Daimee M; Patel V; Prasad A; Chowdhary AA; Jaiswal S; Sriwastava S
Int J Infect Dis; 2021 Mar; 104():390-397. PubMed ID: 33434662
[TBL] [Abstract][Full Text] [Related]
15. Neurological complications of COVID-19.
Newcombe VFJ; Dangayach NS; Sonneville R
Intensive Care Med; 2021 Sep; 47(9):1021-1023. PubMed ID: 34097083
[No Abstract] [Full Text] [Related]
16. SARS-CoV-2 vaccines are not free of neurological side effects.
Finsterer J; Scorza FA
Acta Neurol Scand; 2021 Jul; 144(1):109-110. PubMed ID: 34002379
[No Abstract] [Full Text] [Related]
17. Severe neurological complications in critically ill COVID-19 patients.
Notz Q; Lotz C; Herrmann J; Vogt M; Schlesinger T; Kredel M; Muellges W; Weismann D; Westermaier T; Meybohm P; Kranke P
J Neurol; 2021 May; 268(5):1576-1579. PubMed ID: 32797297
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2: Unique Challenges of the Virus and Vaccines.
Mahmoodpoor A; Sanaie S; Samadi P; Yousefi M; Nader ND
Immunol Invest; 2021 Oct; 50(7):802-809. PubMed ID: 34109900
[TBL] [Abstract][Full Text] [Related]
19. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
20. Neurological complications of COVID-19: a systematic review.
Taherifard E; Taherifard E
Neurol Res; 2020 Nov; 42(11):905-912. PubMed ID: 32698732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
